Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
Gi‐Ae Kim, Joon Ho Moon, Won Kim
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 831-843
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease
Zobair M. Younossi, James M. Paik, Maria Stepanova, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 694-701
Closed Access | Times Cited: 129
Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study
Joon Ho Moon, Seogsong Jeong, Heejoon Jang, et al.
EClinicalMedicine (2023) Vol. 65, pp. 102292-102292
Open Access | Times Cited: 73
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies
Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 454-499
Open Access | Times Cited: 30
Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up
Hun Jee Choe, Joon Ho Moon, Won Kim, et al.
Metabolism (2024), pp. 155800-155800
Closed Access | Times Cited: 26
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation
Byeong Hyun Min, Shivani Devi, Goo Hyun Kwon, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 25
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study
Michihiro Iwaki, Hideki Fujii, Hideki Hayashi, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 225-234
Open Access | Times Cited: 12
Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
Hiroyuki Suzuki, Shigeo Shimose, Hideki Iwamoto, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 263-265
Open Access | Times Cited: 11
Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 577-579
Open Access | Times Cited: 10
Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
Yoon-su Ha, Won Kim, Seungjin Kim
Clinical and Molecular Hepatology (2025)
Open Access | Times Cited: 1
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jihao Xu, Yifan Li, Zhaolan Feng, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 221-221
Open Access | Times Cited: 1
Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression
Sumin Oh, Yang Hyun Baek, Sung‐Ju Jung, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 247-262
Open Access | Times Cited: 7
Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
Hao Chen, Yang Zhou, Haiping Hao, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 8, pp. 724-745
Closed Access | Times Cited: 5
Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
Yewan Park, Jooyi Jung, Seungbong Han, et al.
Alimentary Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 5
Impacts of cardiometabolic risk factors and alcohol consumption on all-cause mortality among MASLD and its subgroups
Mengqi Li, Wenya Chen, You Deng, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 9, pp. 2085-2094
Closed Access | Times Cited: 4
Comparison of NAFLD, MAFLD And MASLD Prevalence And Clinical Characteristics in Asia Adults
Xinjuan Huang, Ruoling Yu, Xinyun Tan, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 1, pp. 102420-102420
Closed Access | Times Cited: 4
Diet quality and physical activity affect metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and etiology-associated steatohepatitis, and compensated advanced chronic liver disease among United States adults: NHANES 2017–2020
Peng Wang, Bo Xia, Shuang Wang
Frontiers in Nutrition (2025) Vol. 11
Open Access
Optimal BMI cutoff for lean MASLD/MetALD and adverse hepatic outcomes in East-Asian populations
Byungyoon Yun, Juyeon Oh, Heejoo Park, et al.
European Journal of Internal Medicine (2025)
Closed Access
Clinical Outcomes in Biopsy-Confirmed Steatotic Liver Disease: A Multicenter Prospective Cohort Study
Gi‐Ae Kim, Heejoon Jang, Moon Young Kim, et al.
(2025)
Closed Access
Prognostic and predictive effects of new steatotic liver disease nomenclatures: a large population‐based study
Huixian Zeng, Letian Fang, Zhiyu Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Is type 2 diabetes a link between lung function and metabolic dysfunction–associated steatotic liver disease? Insights from population studies and Mendelian randomization
Runmin Cao, Yurun Zhang, Ling Cao, et al.
European Journal of Gastroenterology & Hepatology (2025)
Closed Access
Dapansutrile Regulates Mitochondrial Oxidative Stress and Reduces Hepatic Lipid Accumulation in Diabetic Mice
Ying Wu, Jiaqiang Zhou
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 148-148
Open Access
Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver disease
Sang Yoon Lee, Su-Been Lee, Goo-Hyun Kwon, et al.
The Journal of Microbiology (2025) Vol. 63, Iss. 2, pp. e2411002-e2411002
Closed Access
Dietary Patterns Rich in Soybean Products, Vegetables, Fish, Fruits, and Miso Soup Were Inversely Associated with Fatty Liver Index: The Nagahama Study
Y Ueba, Kaori Ikeda, Yasuharu Tabara, et al.
Journal of Nutritional Science and Vitaminology (2025) Vol. 71, Iss. 1, pp. 25-33
Open Access
Impact of binge drinking on alcoholic liver disease
Jisoo Kang, Seol Hee Park, Mushira Khanam, et al.
Archives of Pharmacal Research (2025)
Closed Access
Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank
Tae Seop Lim, Sujin Kwon, Sung A. Bae, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top